Performing Agency. Name: The University of Texas Health Science Center at Houston Address: 7000 Fannin, UCT 1006 City and Zip: Houston, Texas 77030 Contact Person: Xxxx Xxxxxx Telephone: 000-000-0000 Fax number: N/A E-Mail Address: xxx@xxx.xxx.xxx Receiving Agency Name: Health and Human Services Commission Address: 0000 X. 00xx Xxxxxx City and Zip: Austin, TX 78756 Contact Person: Xxxxxx Xxxxxxx Telephone: (000) 000-0000 Fax number: (000) 000-0000 E-Mail Address: Xxxxxx.xxxxxxx@xxxx.xxxxx.xx.xx
Performing Agency. Railroad Commission of Texas The University of Texas at Austin By: By: Name: Xxx Xxxx Name: Xxxxx Xxxxxxxxx Title: Executive Director Title: Business Contracts Administrator 11/1/2023 Date: 2023-10-30 | 15:19:56 PDT DocuSign Envelope ID: B1CA7B97-3E54-4C61-B455-AB947A9B67BA
Performing Agency. UT Health Science Center at San Antonio Department of Radiology, and the Research Imaging Institute 0000 Xxxxx Xxxx Drive, MC 7800 San Antonio, Texas 78229 Attention: UT Health San Xxxxxxx xxx-xxxxxxxx@xxxxxxx.xxx Notice given in any other manner shall be deemed effective only if and when received by the Party to be notified. Either Party may change its address for receiving legal notice by notifying the other Party in writing.
Performing Agency. The University of Texas at Austin, Dell Medical School, Department of Population Health 000 Xxxx 00xx Xxxxxx Austin, TX 78712 Attention: Xxxxx Xxxxxxx Notice given in any other manner shall be deemed effective only if and when received by the Party to be notified. Either Party may change its address for receiving legal notice by notifying the other Party in writing.
Performing Agency. TAMU
1. Draft interim evaluation report due to HHSC from the external evaluator on May 28, 2021 (due to CMS September 30, 2021): o This report must include all results available to date and conform to the report template provided in xxxxx://xxx.xxxxxxxx.xxx/medicaid/section-1115- demo/downloads/evaluation-reports/preparing-the-evaluation- report.pdf. Should HHSC pursue an extension or renewal of the Demonstration, the interim evaluation report is a requirement of the application package. o The external evaluator will give an oral presentation of findings, results, and recommendations to HHSC staff as part of the interim evaluation report review process. The presentation is due on or before May 28, 2021. o The external evaluator will be responsible for responding to HHSC feedback and incorporating associated revisions into the interim evaluation report. o HHSC will submit the interim evaluation report to CMS by September 30, 2021. CMS will provide feedback on the report to HHSC within 60 days of receipt. o HHSC and external evaluators will have 60 days to revise the final interim evaluation report and resubmit to CMS.
2. Draft final evaluation report due to HHSC from the external evaluator on November 20, 2023 (due to CMS March 20, 2024): o This report must include all results of the evaluation and conform to the report template. o The external evaluator will give an oral presentation of findings, results, and recommendations to HHSC staff as part of the final evaluation report review process. The presentation is due on or before November 20, 2023. o The external evaluator will be responsible for responding to HHSC feedback and incorporating associated revisions into the evaluation report. o HHSC will submit the final evaluation report to CMS by November 20, 2023. CMS will provide HHSC with feedback within 60 days. o HHSC and external evaluators will have 60 days to revise the final evaluation report and resubmit to CMS.
3. Semi-annual monitoring reports will be due to HHSC from the external evaluator by November 15 and May 15 for each year of the contract: o The external evaluator must provide updates regarding evaluation activities to be included in HHSC’s semi-annual monitoring reports which are submitted to CMS.
Performing Agency. Name: University of Texas Health Science Center San Antonio Address: 0000 Xxxxx Xxxx Drive MSC 7828 City and Zip Code: San Antonio, Texas 00000-0000 Contact Person: Xxxxx X. Xxxxx, CPA Telephone: (000) 000-0000 E-Mail Address: xxxxxx@xxxxxxx.xxx Agency Number: 745 Name: Health and Human Services Commission Address: P.O. Box 149347 City and Zip Code: Austin, TX 78714 Contact Person: Xxxxx Xxxxx, Contract Manager Telephone: (000) 000-0000 E-Mail Address: Xxxxx.Xxxxx00@xxxx.xxxxx.xx.xx Agency Number: 529
Performing Agency. The Performing Agency Contract Signatory shall be the Chief Administrative Officer of the City (“CAO”), or such other person as designated in writing by the CAO (the “Performing Agency Contract Signatory”). The Performing Agency Contract Signatory is authorized to give notices and to carry out other actions referred to herein, including termination of this Agreement as provided in Section VI. The Performing Agency Contract Signatory also serves as the first level of conflict resolution under this Agreement.
Performing Agency. The University of Texas Health Science Center at Houston 0000 Xxxxxx Xx., Suite 1460 Houston, Texas 77030 Attention: Legal Affairs Notice given in any other manner shall be deemed effective only if and when received by the Party to be notified. Either Party may change its address for receiving legal notice by notifying the other Party in writing.
Performing Agency must notify Civil Rights Office of any civil rights complaints received relating to its performance under this Contract. This notice must be delivered no more than ten (10) calendar days after receipt of a complaint. This notice must be directed to: HHSC Civil Rights Office 000 X. 00xx Xxxxxx, Mail Code W206 Austin, Texas 78751 Phone Toll Free: (000) 000-0000 Phone: (000) 000-0000 Fax: (000) 000-0000.
Performing Agency. UT
1. Provide consulting services of a clinical pharmacist from the Drug Information Center in San Antonio, Texas to review therapeutic criteria and standards for drug use.
2. Revise and update the therapeutic criteria and standards for drug use as directed by HHSC and/or its Drug Utilization Review (DUR) Board.
3. Revise and update the therapeutic prior authorization criteria guide documents annually or in specified timeframes as required by HHSC.
4. Develop new therapeutic criteria and standards for drug use as directed by HHSC and/or DUR Board, to include validating the criteria and standards comply with HHSC’s specifications.
5. Develop provider and patient educational materials and conduct medical literature searches as directed by HHSC.
6. Provide the services of Xxxxxxxx X. Xxxxxxx, PharmD., who will coordinate drug utilization activities with HHSC’s Vendor Drug Program staff to ensure optimal program results. If services are not available by Xxxxxxxx X. Xxxxxxx, PharmD., UT may use the services of an optional clinical pharmacist as approved by HHSC.
7. Communicate as requested by the HHSC Project Manager to describe and provide progress reports on services and deliverables developed and approved under the Contract.
8. Complete services and deliverables in the timeframes requested and specified by HHSC. If timeframe cannot be meet, provide a two week notice to the project manager by request of an extension in written communication.
9. Correct or revise any errors, omissions or other deficiencies in any services or deliverable provided that is not in compliance with the scope of work or other contract requirements as identified by HHSC.
10. Use data obtained from HHSC exclusively in connection with this study, as described in this agreement only in the manner and for the purposes authorized by this agreement.
